Barrett's esophagus: Proton pump inhibitors and chemoprevention I

Triadafilopoulos G, Taddei A, Bechi P, Freschi G, Ringressi MN, Degli'Innocenti DR, Castiglione F, Masini E, Majewski M, Wallner G, Sarosiek J, Dillon JF, Mccallum RC, Dvorak K, Goldman A, Woodland P, Sifrim D, Richter JE, Vieth M, Neumann H, Langner C, Ishimura N, Amano Y, Felix VN (2011)


Publication Type: Book chapter / Article in edited volumes

Publication year: 2011

Journal

Publisher: Blackwell Publishing Inc.

Series: Annals of the New York Academy of Sciences

Book Volume: 1232

Pages Range: 93-113

DOI: 10.1111/j.1749-6632.2011.06047.x

Abstract

The following on proton pump inhibitors and chemoprevention in Barrett's esophagus includes commentaries on normalization of esophageal refluxate; the effects of 5-HT4 agonists on EGF secretion and of lubripristone on chloride channels agents; the role of Campylobacter toxin production; the deleterious effects of unconjugated bile acids; the role of baclofen in nonacid reflux; the threshold for adequate esophageal acid exposure; the effects of proton pump inhibitor (PPI) therapy on normalization of esophageal pH and on cell proliferation; the role of the phenotype of cellular proliferation on the effects of PPI therapy; and the value of Symptom Index and Symptom Association Probability in the evaluation of potential response to treatment. © 2011 New York Academy of Sciences.

Involved external institutions

How to cite

APA:

Triadafilopoulos, G., Taddei, A., Bechi, P., Freschi, G., Ringressi, M.N., Degli'Innocenti, D.R.,... Felix, V.N. (2011). Barrett's esophagus: Proton pump inhibitors and chemoprevention I. In (pp. 93-113). Blackwell Publishing Inc..

MLA:

Triadafilopoulos, George, et al. "Barrett's esophagus: Proton pump inhibitors and chemoprevention I." Blackwell Publishing Inc., 2011. 93-113.

BibTeX: Download